Aurinia Reports Fourth Quarter and Full Year 2022 Financial Results and Company Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Aurinia Reports Fourth Quarter and Full Year 2022 Financial Results and Company Updates

Aurinia Pharmaceuticals (AUPH) Tops Q4 EPS by 9c

February 28, 2023 6:44 AM EST

Aurinia Pharmaceuticals (NASDAQ: AUPH) reported Q4 EPS of ($0.18), $0.09 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $28.4 million versus the consensus estimate of $27.42 million.

For earnings history and earnings-related data on Aurinia Pharmaceuticals (AUPH) click here.

... More